Serum IGFBP1 and IGFBP2 are elevated in idiopathic pulmonary fibrosis patients and IGFBP2 level was significantly reduced by anti-fibrotic therapy (95). Here, IGFBP2 is linked to idiopathic pulmonary fibrosis.